Brucine
Yes, there is evidence that brucine can induce analgesia, particularly in preclinical models of neuropathic, inflammatory, and acute pain, where it reduces pain responses via mechanisms like sodium channel modulation and anti-inflammatory effects. For instance, studies show brucine alleviates neuropathic pain in mice by decreasing sodium currents, and it exhibits protective effects against thermal and chemical stimuli in hot-plate and writhing tests.[1][2][3][4][5] However, strychnine does not induce analgesia—evidence actually points to the opposite, as it often causes hyperalgesia (increased pain sensitivity) or allodynia (pain from non-painful stimuli) by antagonizing glycine receptors, leading to neuronal hyperexcitability.[6][7][8] In fact, strychnine is frequently used in research to block analgesia mediated by glycine receptors, antagonizing pain-relieving effects of other compounds like anesthetics.[9][10][11]
Regarding potential improvements to analgesia: For brucine, yes—this is feasible through structure-activity relationship (SAR) studies and analog development. Brucine's analgesic effects are linked to its dimethoxy-substituted indole alkaloid structure, and modifications (e.g., N-oxide derivatives or changes in alkaloid composition) have shown enhanced anti-inflammatory and pain-modulating activity in models like writhing tests, with reduced toxicity.[2][3][12][13][14][15] Removing or altering strychnine-like elements in total alkaloid fractions from Strychnos nux-vomica can further boost analgesic potency while minimizing convulsant risks.[15] For strychnine, improvement toward analgesia is unlikely and counterproductive, as its core mechanism promotes pain sensitivity; SAR efforts have instead focused on analogs for receptor selectivity (e.g., at glycine or nicotinic receptors) to probe pharmacology, not to create analgesics.[16][17][18][19][20][21]
As for refining stimulant potential: Both compounds have historical use as stimulants at sub-toxic doses—strychnine for enhancing reflexes and alertness (e.g., in old tonics or performance aids), and brucine for similar CNS excitation, though milder.[22][23][24][25][26] Refinement via analogs is possible but challenging due to narrow therapeutic windows and toxicity. SAR studies on strychnine and brucine analogs have identified modifications (e.g., altering ring substituents or creating dimers) that shift affinities at glycine, muscarinic, or nicotinic receptors, potentially tuning stimulant effects while reducing convulsant activity.[27][16][17][28][29][30][18][20][21] However, modern research prioritizes safer alternatives over refining these highly toxic alkaloids for stimulation, given risks like seizures.[31][32][33][34][35]
1. Brucine alleviates neuropathic pain in mice via reducing the current of the sodium channel. Yu, G., Qian, L., Yu, J., Tang, M., Wang, C., Zhou, Y., Geng, X., Zhu, C., Yang, Y., Pan, Y., Shen, X., Tang, Z. 2019. Journal of Ethnopharmacology, 233, 56–63. 10.1016/j.jep.2018.12.045
2. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. Yin, W., Wang, Y., Liu, L., Sui, J., Wang, Y., Wang, J., Cai, F., Zhou, M., Chen, L., Wang, Y. 2003. Journal of Ethnopharmacology, 88, 205–214. 10.1016/s0378-8741(03)00245-1
3. A Novel Brucine Gel Transdermal Delivery System Designed for Anti-Inflammatory and Anti-Arthritic Activities. Wu, P., Liang, Q., Feng, P., Li, C., Yang, C., Liang, H., Tang, H., Shuai, C. 2017. International Journal of Molecular Sciences, 18, 757. 10.3390/ijms18040757
4. Preparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterization. Qin, J.M., Yin, P.H., Wang, Q., Chen, J., Yuan, S.J., Yin, J. 2008. Acta Pharmacologica Sinica, 29, 246–253. 10.1111/j.1745-7254.2008.00733.x
5. Brucine: A Review of Phytochemistry, Pharmacology, and Toxicology. Lu, L., Huang, R., Wu, Y., Jin, J.-M., Chen, H.-Z., Zhang, L.-J., Luan, X. 2020. Frontiers in Pharmacology, 11, 377. 10.3389/fphar.2020.00377
6. Hyperalgesia induced by altered glycinergic activity at the spinal cord. Beyer, C., Roberts, L.A., Komisaruk, B.R. 1985. Life Sciences, 37, 875–882. 10.1016/0024-3205(85)90523-5
7. Effect of intrathecal glycine and related amino acids on the allodynia and hyperalgesic action of strychnine or bicuculline in mice. Tan, P.H., Chou, Y.H., Chang, Y.L., Hsieh, S.T., Lin, C.R. 2010. Acta Anaesthesiologica Taiwanica, 48, 15–22. 10.1016/S1875-4597(10)60003-5
8. Visceral, inflammatory and neuropathic pain in glycine receptor alpha3-deficient mice. Harvey, R.J., Ahmadi, S., Zeilhofer, H.U., Müller, U. 2005. NeuroReport, 16, 2025–2028. 10.1097/00001756-200512190-00011
9. Strychnine-sensitive glycine receptors mediate the analgesic effect of emulsified isoflurane on thermal nociception but not on chemical nociception. Chen, Y., Dai, T.J., Zeng, Y.M. 2007. Basic & Clinical Pharmacology & Toxicology, 100, 165–169. 10.1111/j.1742-7843.2006.00031.x
10. Inhibitory Glycine Receptors: An Update. Dutertre, S., Becker, C.M., Betz, H. 2012. The Journal of Biological Chemistry, 287, 40216–40223. 10.1074/jbc.R112.408229
11. Modulation of Glycine Receptor-Mediated Pain Signaling in vitro and in vivo by Glucose. Hussein, R.A., Ahmed, M., Breitinger, H.-G., Breitinger, U. 2019. Frontiers in Molecular Neuroscience, 12, 280. 10.3389/fnmol.2019.00280
12. Analgesic and anti-inflammatory activity and pharmacokinetics of alkaloids from seeds of Strychnos nux-vomica after transdermal administration: effect of changes in alkaloid composition. Chen, J., Wang, W., Zhang, Q., Li, F., Lei, T., Luo, D., Zhou, H., Yang, B. 2012. Journal of Ethnopharmacology, 139, 181–188. 10.1016/j.jep.2011.10.038
13. Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors. Jensen, A.A., Gharagozloo, P., Birdsall, N.J., Zlotos, D.P. 2006. European Journal of Pharmacology, 539, 27–33. 10.1016/j.ejphar.2006.04.010
14. A Combination of In Silico ADMET Prediction, In Vivo Toxicity Evaluation, and Potential Mechanism Exploration of Brucine and Brucine N-oxide—A Comparative Study. Gao, Y., Guo, L., Han, Y., Zhang, J., Dai, Z., Ma, S. 2023. Molecules, 28, 1341. 10.3390/molecules28031341
15. Analgesic and anti-inflammatory activity and pharmacokinetics of alkaloids from seeds of Strychnos nux-vomica after transdermal administration: effect of changes in alkaloid composition. Chen, J., Wang, W., Zhang, Q., Li, F., Lei, T., Luo, D., Zhou, H., Yang, B. 2012. Journal of Ethnopharmacology, 139, 181–188. 10.1016/j.jep.2011.10.038
16. Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective. Zlotos, D.P., Mandour, Y.M., Jensen, A.A. 2022. Natural Product Reports, 39, 1910–1937. 10.1039/D1NP00079A
17. Modulators of the Inhibitory Glycine Receptor. Breitinger, U., Breitinger, H.-G. 2020. ACS Chemical Neuroscience, 11, 1706–1725. 10.1021/acschemneuro.0c00054
18. Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors. Jensen, A.A., Gharagozloo, P., Birdsall, N.J., Zlotos, D.P. 2006. European Journal of Pharmacology, 539, 27–33. 10.1016/j.ejphar.2006.04.010
19. Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective. Zlotos, D.P., Mandour, Y.M., Jensen, A.A. 2022. Natural Product Reports, 39, 1910–1937. 10.1039/D1NP00079A
20. Modulators of the Inhibitory Glycine Receptor. Breitinger, U., Breitinger, H.-G. 2020. ACS Chemical Neuroscience, 11, 1706–1725. 10.1021/acschemneuro.0c00054
21. Inhibitory Glycine Receptors: An Update. Dutertre, S., Becker, C.M., Betz, H. 2012. The Journal of Biological Chemistry, 287, 40216–40223. 10.1074/jbc.R112.408229
22. History of Respiratory Stimulants. Peppin, J.F., Pergolizzi, J.V. Jr, Fudin, J., Meyer, T.A., Raffa, R.B. 2021. Journal of Pain Research, 14, 1043–1049. 10.2147/JPR.S298607
23. Strychnine. Wikipedia contributors. Accessed December 13, 2025. Wikipedia, The Free Encyclopedia.
24. History of Respiratory Stimulants. Izumizaki, M. 2021. Journal of Clinical Medicine, 10, 1696. 10.3390/jcm10081696
25. Brucine: A Review of Phytochemistry, Pharmacology, and Toxicology. Lu, L., Huang, R., Wu, Y., Jin, J.-M., Chen, H.-Z., Zhang, L.-J., Luan, X. 2020. Frontiers in Pharmacology, 11, 377. 10.3389/fphar.2020.00377
26. History of Respiratory Stimulants. Peppin, J.F., Pergolizzi, J.V. Jr, Fudin, J., Meyer, T.A., Raffa, R.B. 2021. Journal of Pain Research, 14, 1043–1049. 10.2147/JPR.S298607
27. Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective. Zlotos, D.P., Mandour, Y.M., Jensen, A.A. 2022. Natural Product Reports, 39, 1910–1937. 10.1039/D1NP00079A
28. Modulators of the Inhibitory Glycine Receptor. Breitinger, U., Breitinger, H.-G. 2020. ACS Chemical Neuroscience, 11, 1706–1725. 10.1021/acschemneuro.0c00054
29. Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors. Jensen, A.A., Gharagozloo, P., Birdsall, N.J., Zlotos, D.P. 2006. European Journal of Pharmacology, 539, 27–33. 10.1016/j.ejphar.2006.04.010
30. A Combination of In Silico ADMET Prediction, In Vivo Toxicity Evaluation, and Potential Mechanism Exploration of Brucine and Brucine N-oxide—A Comparative Study. Gao, Y., Guo, L., Han, Y., Zhang, J., Dai, Z., Ma, S. 2023. Molecules, 28, 1341. 10.3390/molecules28031341
31. Strychnine Toxicity. Otter, J., D'Orazio, J.L. 2024. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
32. Strychnine. Wikipedia contributors. Accessed December 13, 2025. Wikipedia, The Free Encyclopedia.
33. History of Respiratory Stimulants. Peppin, J.F., Pergolizzi, J.V. Jr, Fudin, J., Meyer, T.A., Raffa, R.B. 2021. Journal of Pain Research, 14, 1043–1049. 10.2147/JPR.S298607
34. History of Respiratory Stimulants. Izumizaki, M. 2021. Journal of Clinical Medicine, 10, 1696. 10.3390/jcm10081696
35. Brucine: A Review of Phytochemistry, Pharmacology, and Toxicology. Lu, L., Huang, R., Wu, Y., Jin, J.-M., Chen, H.-Z., Zhang, L.-J., Luan, X. 2020. Frontiers in Pharmacology, 11, 377. 10.3389/fphar.2020.00377
This text was generated by Grok.
Regarding potential improvements to analgesia: For brucine, yes—this is feasible through structure-activity relationship (SAR) studies and analog development. Brucine's analgesic effects are linked to its dimethoxy-substituted indole alkaloid structure, and modifications (e.g., N-oxide derivatives or changes in alkaloid composition) have shown enhanced anti-inflammatory and pain-modulating activity in models like writhing tests, with reduced toxicity.[2][3][12][13][14][15] Removing or altering strychnine-like elements in total alkaloid fractions from Strychnos nux-vomica can further boost analgesic potency while minimizing convulsant risks.[15] For strychnine, improvement toward analgesia is unlikely and counterproductive, as its core mechanism promotes pain sensitivity; SAR efforts have instead focused on analogs for receptor selectivity (e.g., at glycine or nicotinic receptors) to probe pharmacology, not to create analgesics.[16][17][18][19][20][21]
As for refining stimulant potential: Both compounds have historical use as stimulants at sub-toxic doses—strychnine for enhancing reflexes and alertness (e.g., in old tonics or performance aids), and brucine for similar CNS excitation, though milder.[22][23][24][25][26] Refinement via analogs is possible but challenging due to narrow therapeutic windows and toxicity. SAR studies on strychnine and brucine analogs have identified modifications (e.g., altering ring substituents or creating dimers) that shift affinities at glycine, muscarinic, or nicotinic receptors, potentially tuning stimulant effects while reducing convulsant activity.[27][16][17][28][29][30][18][20][21] However, modern research prioritizes safer alternatives over refining these highly toxic alkaloids for stimulation, given risks like seizures.[31][32][33][34][35]
1. Brucine alleviates neuropathic pain in mice via reducing the current of the sodium channel. Yu, G., Qian, L., Yu, J., Tang, M., Wang, C., Zhou, Y., Geng, X., Zhu, C., Yang, Y., Pan, Y., Shen, X., Tang, Z. 2019. Journal of Ethnopharmacology, 233, 56–63. 10.1016/j.jep.2018.12.045
2. Analgesic and anti-inflammatory properties of brucine and brucine N-oxide extracted from seeds of Strychnos nux-vomica. Yin, W., Wang, Y., Liu, L., Sui, J., Wang, Y., Wang, J., Cai, F., Zhou, M., Chen, L., Wang, Y. 2003. Journal of Ethnopharmacology, 88, 205–214. 10.1016/s0378-8741(03)00245-1
3. A Novel Brucine Gel Transdermal Delivery System Designed for Anti-Inflammatory and Anti-Arthritic Activities. Wu, P., Liang, Q., Feng, P., Li, C., Yang, C., Liang, H., Tang, H., Shuai, C. 2017. International Journal of Molecular Sciences, 18, 757. 10.3390/ijms18040757
4. Preparation of liposomal brucine and its pharmaceutical/pharmacodynamic characterization. Qin, J.M., Yin, P.H., Wang, Q., Chen, J., Yuan, S.J., Yin, J. 2008. Acta Pharmacologica Sinica, 29, 246–253. 10.1111/j.1745-7254.2008.00733.x
5. Brucine: A Review of Phytochemistry, Pharmacology, and Toxicology. Lu, L., Huang, R., Wu, Y., Jin, J.-M., Chen, H.-Z., Zhang, L.-J., Luan, X. 2020. Frontiers in Pharmacology, 11, 377. 10.3389/fphar.2020.00377
6. Hyperalgesia induced by altered glycinergic activity at the spinal cord. Beyer, C., Roberts, L.A., Komisaruk, B.R. 1985. Life Sciences, 37, 875–882. 10.1016/0024-3205(85)90523-5
7. Effect of intrathecal glycine and related amino acids on the allodynia and hyperalgesic action of strychnine or bicuculline in mice. Tan, P.H., Chou, Y.H., Chang, Y.L., Hsieh, S.T., Lin, C.R. 2010. Acta Anaesthesiologica Taiwanica, 48, 15–22. 10.1016/S1875-4597(10)60003-5
8. Visceral, inflammatory and neuropathic pain in glycine receptor alpha3-deficient mice. Harvey, R.J., Ahmadi, S., Zeilhofer, H.U., Müller, U. 2005. NeuroReport, 16, 2025–2028. 10.1097/00001756-200512190-00011
9. Strychnine-sensitive glycine receptors mediate the analgesic effect of emulsified isoflurane on thermal nociception but not on chemical nociception. Chen, Y., Dai, T.J., Zeng, Y.M. 2007. Basic & Clinical Pharmacology & Toxicology, 100, 165–169. 10.1111/j.1742-7843.2006.00031.x
10. Inhibitory Glycine Receptors: An Update. Dutertre, S., Becker, C.M., Betz, H. 2012. The Journal of Biological Chemistry, 287, 40216–40223. 10.1074/jbc.R112.408229
11. Modulation of Glycine Receptor-Mediated Pain Signaling in vitro and in vivo by Glucose. Hussein, R.A., Ahmed, M., Breitinger, H.-G., Breitinger, U. 2019. Frontiers in Molecular Neuroscience, 12, 280. 10.3389/fnmol.2019.00280
12. Analgesic and anti-inflammatory activity and pharmacokinetics of alkaloids from seeds of Strychnos nux-vomica after transdermal administration: effect of changes in alkaloid composition. Chen, J., Wang, W., Zhang, Q., Li, F., Lei, T., Luo, D., Zhou, H., Yang, B. 2012. Journal of Ethnopharmacology, 139, 181–188. 10.1016/j.jep.2011.10.038
13. Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors. Jensen, A.A., Gharagozloo, P., Birdsall, N.J., Zlotos, D.P. 2006. European Journal of Pharmacology, 539, 27–33. 10.1016/j.ejphar.2006.04.010
14. A Combination of In Silico ADMET Prediction, In Vivo Toxicity Evaluation, and Potential Mechanism Exploration of Brucine and Brucine N-oxide—A Comparative Study. Gao, Y., Guo, L., Han, Y., Zhang, J., Dai, Z., Ma, S. 2023. Molecules, 28, 1341. 10.3390/molecules28031341
15. Analgesic and anti-inflammatory activity and pharmacokinetics of alkaloids from seeds of Strychnos nux-vomica after transdermal administration: effect of changes in alkaloid composition. Chen, J., Wang, W., Zhang, Q., Li, F., Lei, T., Luo, D., Zhou, H., Yang, B. 2012. Journal of Ethnopharmacology, 139, 181–188. 10.1016/j.jep.2011.10.038
16. Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective. Zlotos, D.P., Mandour, Y.M., Jensen, A.A. 2022. Natural Product Reports, 39, 1910–1937. 10.1039/D1NP00079A
17. Modulators of the Inhibitory Glycine Receptor. Breitinger, U., Breitinger, H.-G. 2020. ACS Chemical Neuroscience, 11, 1706–1725. 10.1021/acschemneuro.0c00054
18. Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors. Jensen, A.A., Gharagozloo, P., Birdsall, N.J., Zlotos, D.P. 2006. European Journal of Pharmacology, 539, 27–33. 10.1016/j.ejphar.2006.04.010
19. Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective. Zlotos, D.P., Mandour, Y.M., Jensen, A.A. 2022. Natural Product Reports, 39, 1910–1937. 10.1039/D1NP00079A
20. Modulators of the Inhibitory Glycine Receptor. Breitinger, U., Breitinger, H.-G. 2020. ACS Chemical Neuroscience, 11, 1706–1725. 10.1021/acschemneuro.0c00054
21. Inhibitory Glycine Receptors: An Update. Dutertre, S., Becker, C.M., Betz, H. 2012. The Journal of Biological Chemistry, 287, 40216–40223. 10.1074/jbc.R112.408229
22. History of Respiratory Stimulants. Peppin, J.F., Pergolizzi, J.V. Jr, Fudin, J., Meyer, T.A., Raffa, R.B. 2021. Journal of Pain Research, 14, 1043–1049. 10.2147/JPR.S298607
23. Strychnine. Wikipedia contributors. Accessed December 13, 2025. Wikipedia, The Free Encyclopedia.
24. History of Respiratory Stimulants. Izumizaki, M. 2021. Journal of Clinical Medicine, 10, 1696. 10.3390/jcm10081696
25. Brucine: A Review of Phytochemistry, Pharmacology, and Toxicology. Lu, L., Huang, R., Wu, Y., Jin, J.-M., Chen, H.-Z., Zhang, L.-J., Luan, X. 2020. Frontiers in Pharmacology, 11, 377. 10.3389/fphar.2020.00377
26. History of Respiratory Stimulants. Peppin, J.F., Pergolizzi, J.V. Jr, Fudin, J., Meyer, T.A., Raffa, R.B. 2021. Journal of Pain Research, 14, 1043–1049. 10.2147/JPR.S298607
27. Strychnine and its mono- and dimeric analogues: a pharmaco-chemical perspective. Zlotos, D.P., Mandour, Y.M., Jensen, A.A. 2022. Natural Product Reports, 39, 1910–1937. 10.1039/D1NP00079A
28. Modulators of the Inhibitory Glycine Receptor. Breitinger, U., Breitinger, H.-G. 2020. ACS Chemical Neuroscience, 11, 1706–1725. 10.1021/acschemneuro.0c00054
29. Pharmacological characterisation of strychnine and brucine analogues at glycine and alpha7 nicotinic acetylcholine receptors. Jensen, A.A., Gharagozloo, P., Birdsall, N.J., Zlotos, D.P. 2006. European Journal of Pharmacology, 539, 27–33. 10.1016/j.ejphar.2006.04.010
30. A Combination of In Silico ADMET Prediction, In Vivo Toxicity Evaluation, and Potential Mechanism Exploration of Brucine and Brucine N-oxide—A Comparative Study. Gao, Y., Guo, L., Han, Y., Zhang, J., Dai, Z., Ma, S. 2023. Molecules, 28, 1341. 10.3390/molecules28031341
31. Strychnine Toxicity. Otter, J., D'Orazio, J.L. 2024. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing.
32. Strychnine. Wikipedia contributors. Accessed December 13, 2025. Wikipedia, The Free Encyclopedia.
33. History of Respiratory Stimulants. Peppin, J.F., Pergolizzi, J.V. Jr, Fudin, J., Meyer, T.A., Raffa, R.B. 2021. Journal of Pain Research, 14, 1043–1049. 10.2147/JPR.S298607
34. History of Respiratory Stimulants. Izumizaki, M. 2021. Journal of Clinical Medicine, 10, 1696. 10.3390/jcm10081696
35. Brucine: A Review of Phytochemistry, Pharmacology, and Toxicology. Lu, L., Huang, R., Wu, Y., Jin, J.-M., Chen, H.-Z., Zhang, L.-J., Luan, X. 2020. Frontiers in Pharmacology, 11, 377. 10.3389/fphar.2020.00377
This text was generated by Grok.
Comments
Post a Comment